
Empagliflozin is a мощный, селективный sodium glucose co-transporter-2 ингибитор that is in development for the treatment of type 2 diabetes. Empagliflozin is an ингибитор of the sodium glucose co-transporter-2 (SGLT-2), which is found almost exclusively in
Empagliflozin is a potent, selective sodium glucose co-transporter-2 inhibitor that is in development for the treatment of type 2 diabetes. Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), which is found almost exclusively in
Вращайте мышью · Колесо — масштаб
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.